Skip to main content
Profound Medical Corp. logo

Profound Medical Corp. — Investor Relations & Filings

Ticker · PROF TSX Manufacturing
Filings indexed 659 across all filing types
Latest filing 2021-05-12 Regulatory Filings
Country CA Canada
Listing TSX PROF

About Profound Medical Corp.

https://profoundmedical.com/

Profound Medical Corp. is a commercial-stage medical technology company specializing in incision-free ablative therapies. Its core product is TULSA-PRO®, a therapeutic platform designed for the treatment of localized prostate cancer, radiorecurrent prostate cancer, and benign prostatic hyperplasia (BPH). TULSA-PRO utilizes a robotically controlled, transurethral ultrasound ablation procedure guided by real-time Magnetic Resonance (MR) imaging. This system employs closed-loop temperature feedback to ensure precise and customizable tissue ablation, prioritizing patient safety and minimizing complications. The technology merges MR imaging, thermal ultrasound, and robotics to offer a durable and accurate treatment delivery method.

Recent filings

Filing Released Lang Actions
52-109F2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings
2021-05-12 English
52-109F2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings
2021-05-12 English
Interim financial statements/report – English.pdf
Regulatory Filings
2021-05-12 English
News release - English.pdf
Regulatory Filings
2021-05-12 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing a commercial agreement between Profound Medical Corp. and Akumin Inc. It discusses the business arrangement, product details, and forward-looking statements. There are no financial statements, regulatory filings, or detailed financial data presented. The content is typical of a Capital/Financing Update as it relates to a business development and commercial agreement. It is not an earnings release, annual report, or any other regulatory filing. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2021-05-06 English
Certificate re dissemination to shareholders.pdf
Regulatory Filings
2021-04-27 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.